+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Remdesivir: Market Share, and Growth Analysis by Product Type (Injection, Oral), Application, End User, Technology

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • OG Analysis
  • ID: 6115665
The Remdesivir Market size is valued at USD 10.7 billion in 2025 and is projected to reach USD 74.5 billion by 2033, registering a compound annual growth rate (CAGR) of 27.5% over the forecast period.

The Remdesivir Market emerged as a vital segment within the antiviral therapeutics landscape following its emergency use and eventual approval during the COVID-19 pandemic. Developed by Gilead Sciences, Remdesivir - marketed as Veklury - is a broad-spectrum antiviral drug initially designed to treat Ebola but later repurposed for COVID-19 after clinical evidence showed it could shorten recovery time in hospitalized patients. The drug’s primary application has been in managing moderate to severe cases of COVID-19, particularly in high-risk individuals. Although its usage declined after the global pandemic peaked, Remdesivir remains relevant for treating severe viral infections and is being explored for broader antiviral potential. The market is influenced by global infection trends, healthcare infrastructure, licensing agreements, and government stockpiling strategies. As part of pandemic preparedness protocols and ongoing virus surveillance, Remdesivir maintains a critical position in treatment arsenals, especially in developing economies and hospital settings where alternative therapeutics may be limited.

In 2024, the Remdesivir market experienced steady yet subdued activity compared to its peak in 2020-2021. The year saw continued usage in hospitals for treating COVID-19 complications, especially in immunocompromised patients and regions with lower vaccination coverage or limited access to newer antivirals. Several countries, particularly in Asia, Latin America, and Africa, maintained Remdesivir procurement agreements as part of their emergency health response inventory. Manufacturers including Gilead and its licensed partners adapted production volumes to meet fluctuating demand, while generic versions remained crucial in low - and middle-income countries. In parallel, research continued into Remdesivir’s effectiveness against other viral infections, including Nipah virus and potential new coronaviruses. Regulatory agencies encouraged data collection and real-world evidence generation to assess long-term safety and efficacy. While not in the spotlight as during the pandemic, Remdesivir retained a stable market presence, underpinned by its role in infectious disease preparedness and hospital-based antiviral therapies.

Looking ahead to 2025 and beyond, the Remdesivir market is likely to evolve from pandemic-focused treatment toward broader inclusion in antiviral portfolios. New applications may arise as research deepens into its activity against other RNA viruses and its use in combination therapies. With global attention shifting to future pandemic readiness, governments are expected to maintain strategic reserves of Remdesivir and other antivirals. The market will also benefit from continued clinical trials exploring its use in respiratory virus outbreaks, especially in vulnerable populations. While newer oral antivirals may dominate outpatient treatment landscapes, Remdesivir will continue to be a key option in inpatient settings where IV formulations are standard. The expansion of global healthcare infrastructure and increased investment in infectious disease control will sustain baseline demand. Moreover, improved formulations, including long-acting injectables or combination regimens, could extend its relevance in hospital protocols. As viral threats evolve, Remdesivir’s adaptability and proven efficacy will ensure it remains a strategic therapeutic asset.

Key Insights: Remdesivir Market

  • Ongoing clinical studies are evaluating Remdesivir’s effectiveness against a broader range of RNA viruses beyond COVID-19, potentially opening new treatment indications.
  • Generic production and licensing agreements are ensuring affordable access to Remdesivir in low - and middle-income countries, supporting equitable antiviral distribution.
  • Healthcare systems are integrating Remdesivir into pandemic preparedness protocols and emergency stockpiles for future infectious disease outbreaks.
  • Combination therapies featuring Remdesivir are being explored to improve treatment outcomes and prevent antiviral resistance in hospitalized patients.
  • Research into improved delivery methods, such as long-acting injectables or aerosolized forms, is gaining interest to enhance administration efficiency in clinical settings.
  • Persistent circulation of COVID-19 variants and hospitalizations among immunocompromised patients continue to drive demand for intravenous antiviral options like Remdesivir.
  • Government contracts and public health preparedness programs are maintaining steady procurement of Remdesivir as part of pandemic response strategies.
  • Global health initiatives and support from organizations like WHO and GAVI are promoting the availability of essential antiviral drugs in underserved regions.
  • Expanding research into antiviral drugs for emerging infectious diseases is sustaining scientific and commercial interest in repurposing and enhancing Remdesivir.
  • The shift toward oral antivirals and outpatient treatments poses a challenge to Remdesivir’s hospital-based IV formulation, potentially limiting its long-term competitiveness and broader use outside acute care settings.

Remdesivir Market Segmentation

By Product Type:

  • Injection
  • Oral

By Application:

  • COVID-19
  • Other Viral Infections

By End User:

  • Hospitals
  • Clinics
  • Home Care

By Technology:

  • Nanotechnology
  • Biopharmaceuticals

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy

By Geography:

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Remdesivir Market Size Data, Trends, Growth Opportunities, and Restraining Factors:

  • This comprehensive Remdesivir market report delivers updated market size estimates from 2024 to 2034, offering in-depth analysis of the latest Remdesivir market trends, short-term and long-term growth drivers, competitive landscape, and new business opportunities. The report presents growth forecasts across key Remdesivir types, applications, and major segments, alongside detailed insights into the current Remdesivir market scenario to support companies in formulating effective market strategies.
  • The Remdesivir market outlook thoroughly examines the impact of ongoing supply chain disruptions and geopolitical issues worldwide. Factors such as trade tariffs, regulatory restrictions, production losses, and the emergence of alternatives or substitutes are carefully considered in the Remdesivir market size projections. Additionally, the analysis highlights the effects of inflation and correlates past economic downturns with current Remdesivir market trends, providing actionable intelligence for stakeholders to navigate the evolving Remdesivir business environment with precision.

Remdesivir Market Competition, Intelligence, Key Players, and Winning Strategies to 2034:

  • The 2025 Remdesivir Market Research Report identifies winning strategies for companies to register increased sales and improve market share.
  • Opinions from senior executives from leading companies in the Remdesivir market are imbibed thoroughly and the Remdesivir industry expert predictions on the economic downturn, technological advancements in the Remdesivir market, and customized strategies specific to a product and geography are mentioned.
  • The Remdesivir market report is a source of comprehensive data and analysis of the industry, helping businesses to make informed decisions and stay ahead of the competition. The Remdesivir market study assists investors in analyzing On Remdesivir business prospects by region, key countries, and top companies' information to channel their investments.
  • The report provides insights into consumer behavior and preferences, including their buying patterns, brand loyalty, and factors influencing their purchasing decisions. It also includes an analysis of the regulatory environment and its impact on the Remdesivir industry. Shifting consumer demand despite declining GDP and burgeoning interest rates to control surging inflation is well detailed.

What's Included in the Report?

  • Global Remdesivir market size and growth projections, 2024-2034
  • North America Remdesivir market size and growth forecasts, 2024-2034 (United States, Canada, Mexico)
  • Europe market size and growth forecasts, 2024-2034 (Germany, France, United Kingdom, Italy, Spain)
  • Asia-Pacific Remdesivir market size and growth forecasts, 2024-2034 (China, India, Japan, South Korea, Australia)
  • Middle East Africa Remdesivir market size and growth estimate, 2024-2034 (Middle East, Africa)
  • South and Central America Remdesivir market size and growth outlook, 2024-2034 (Brazil, Argentina, Chile)
  • Remdesivir market size, share and CAGR of key products, applications, and other verticals, 2024-2034
  • Short- and long-term Remdesivir market trends, drivers, challenges, and opportunities
  • Remdesivir market insights, Porter’s Five Forces analysis
  • Profiles of 5 leading companies in the industry - overview, key strategies, financials, product portfolio and SWOT analysis
  • Latest market news and developments

Key Questions Answered in This Report:

  • What is the current Remdesivir market size at global, regional, and country levels?
  • What is the market penetration of different types, Applications, processes/technologies, and distribution/sales channels of the Remdesivir market?
  • What will be the impact of economic slowdown/recission on Remdesivir demand/sales?
  • How has the global Remdesivir market evolved in past years and what will be the future trajectory?
  • What is the impact of growing inflation, Russia-Ukraine war on the Remdesivir market forecast?
  • What are the Supply chain challenges for Remdesivir?
  • What are the potential regional Remdesivir markets to invest in?
  • What is the product evolution and high-performing products to focus in the Remdesivir market?
  • What are the key driving factors and opportunities in the industry?
  • Who are the key players in Remdesivir market and what is the degree of competition/Remdesivir market share?
  • What is the market structure /Remdesivir Market competitive Intelligence?

Available Customizations:

The standard syndicate report is designed to serve the common interests of Remdesivir Market players across the value chain, and include selective data and analysis from entire research findings as per the scope and price of the publication.

However, to precisely match the specific research requirements of individual clients, several customization options are offered to include the data and analysis of interest in the final deliverable.

Some of the customization requests are as mentioned below:

  • Segmentation of choice - Clients can seek customization to modify/add a market division for types/applications/end-uses/processes of their choice.
  • Remdesivir Pricing and Margins Across the Supply Chain, Remdesivir Price Analysis / International Trade Data / Import-Export Analysis.
  • Supply Chain Analysis, Supply-Demand Gap Analysis, PESTLE Analysis, Macro-Economic Analysis, and other Remdesivir market analytics.
  • Processing and manufacturing requirements, Patent Analysis, Technology Trends, and Product Innovations.
  • Further, the client can seek customization to break down geographies as per their requirements for specific countries/country groups such as South East Asia, Central Asia, Emerging and Developing Asia, Western Europe, Eastern Europe, Benelux, Emerging and Developing Europe, Nordic countries, North Africa, Sub-Saharan Africa, Caribbean, The Middle East and North Africa (MENA), Gulf Cooperation Council (GCC) or any other.
  • Capital Requirements, Income Projections, Profit Forecasts, and other parameters to prepare a detailed project report to present to Banks/Investment Agencies.

Additional support:

  • All the data presented in tables and charts of the report is provided in a separate Excel document
  • Print authentication allowed on purchase of online versions
  • 10% free customization to include any specific data/analysis to match the requirement
  • 7 days of analyst support

This product will be delivered within 1-3 business days.

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Remdesivir Market Latest Trends, Drivers and Challenges, 2024-2034
2.1 Remdesivir Market Overview
2.2 Market Strategies of Leading Remdesivir Companies
2.3 Remdesivir Market Insights, 2024-2034
2.3.1 Leading Remdesivir Types, 2024-2034
2.3.2 Leading Remdesivir End-User industries, 2024-2034
2.3.3 Fast-Growing countries for Remdesivir sales, 2024-2034
2.4 Remdesivir Market Drivers and Restraints
2.4.1 Remdesivir Demand Drivers to 2034
2.4.2 Remdesivir Challenges to 2034
2.5 Remdesivir Market - Five Forces Analysis
2.5.1 Remdesivir Industry Attractiveness Index, 2024
2.5.2 Threat of New Entrants
2.5.3 Bargaining Power of Suppliers
2.5.4 Bargaining Power of Buyers
2.5.5 Intensity of Competitive Rivalry
2.5.6 Threat of Substitutes
3. Global Remdesivir Market Value, Market Share, and Forecast to 2034
3.1 Global Remdesivir Market Overview, 2024
3.2 Global Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
3.3 Global Remdesivir Market Size and Share Outlook By Product, 2024-2034
3.4 Global Remdesivir Market Size and Share Outlook By Application, 2024-2034
3.5 Global Remdesivir Market Size and Share Outlook By End User, 2024-2034
3.6 Global Remdesivir Market Size and Share Outlook By Technology, 2024-2034
3.7 Global Remdesivir Market Size and Share Outlook by Region, 2024-2034
4. Asia Pacific Remdesivir Market Value, Market Share and Forecast to 2034
4.1 Asia Pacific Remdesivir Market Overview, 2024
4.2 Asia Pacific Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
4.3 Asia Pacific Remdesivir Market Size and Share Outlook By Product, 2024-2034
4.4 Asia Pacific Remdesivir Market Size and Share Outlook By Application, 2024-2034
4.5 Asia Pacific Remdesivir Market Size and Share Outlook By End User, 2024-2034
4.6 Asia Pacific Remdesivir Market Size and Share Outlook By Technology, 2024-2034
4.7 Asia Pacific Remdesivir Market Size and Share Outlook by Country, 2024-2034
5. Europe Remdesivir Market Value, Market Share, and Forecast to 2034
5.1 Europe Remdesivir Market Overview, 2024
5.2 Europe Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
5.3 Europe Remdesivir Market Size and Share Outlook By Product, 2024-2034
5.4 Europe Remdesivir Market Size and Share Outlook By Application, 2024-2034
5.5 Europe Remdesivir Market Size and Share Outlook By End User, 2024-2034
5.6 Europe Remdesivir Market Size and Share Outlook By Technology, 2024-2034
5.7 Europe Remdesivir Market Size and Share Outlook by Country, 2024-2034
6. North America Remdesivir Market Value, Market Share and Forecast to 2034
6.1 North America Remdesivir Market Overview, 2024
6.2 North America Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
6.3 North America Remdesivir Market Size and Share Outlook By Product, 2024-2034
6.4 North America Remdesivir Market Size and Share Outlook By Application, 2024-2034
6.5 North America Remdesivir Market Size and Share Outlook By End User, 2024-2034
6.6 North America Remdesivir Market Size and Share Outlook By Technology, 2024-2034
6.7 North America Remdesivir Market Size and Share Outlook by Country, 2024-2034
7. South and Central America Remdesivir Market Value, Market Share and Forecast to 2034
7.1 South and Central America Remdesivir Market Overview, 2024
7.2 South and Central America Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
7.3 South and Central America Remdesivir Market Size and Share Outlook By Product, 2024-2034
7.4 South and Central America Remdesivir Market Size and Share Outlook By Application, 2024-2034
7.5 South and Central America Remdesivir Market Size and Share Outlook By End User, 2024-2034
7.6 South and Central America Remdesivir Market Size and Share Outlook By Technology, 2024-2034
7.7 South and Central America Remdesivir Market Size and Share Outlook by Country, 2024-2034
8. Middle East Africa Remdesivir Market Value, Market Share and Forecast to 2034
8.1 Middle East Africa Remdesivir Market Overview, 2024
8.2 Middle East and Africa Remdesivir Market Revenue and Forecast, 2024-2034 (US$ Million)
8.3 Middle East Africa Remdesivir Market Size and Share Outlook By Product, 2024-2034
8.4 Middle East Africa Remdesivir Market Size and Share Outlook By Application, 2024-2034
8.5 Middle East Africa Remdesivir Market Size and Share Outlook By End User, 2024-2034
8.6 Middle East Africa Remdesivir Market Size and Share Outlook By Technology, 2024-2034
8.7 Middle East Africa Remdesivir Market Size and Share Outlook by Country, 2024-2034
9. Remdesivir Market Structure
9.1 Key Players
9.2 Remdesivir Companies - Key Strategies and Financial Analysis
9.2.1 Snapshot
9.2.3 Business Description
9.2.4 Products and Services
9.2.5 Financial Analysis
10. Remdesivir Industry Recent Developments
11 Appendix
11.1 Publisher Expertise
11.2 Research Methodology
11.3 Annual Subscription Plans
11.4 Contact Information

Table Information